645 related articles for article (PubMed ID: 16084157)
1. Facilitated percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: results from the prematurely terminated ADdressing the Value of facilitated ANgioplasty after Combination therapy or Eptifibatide monotherapy in acute Myocardial Infarction (ADVANCE MI) trial.
ADVANCE MI Investigators
Am Heart J; 2005 Jul; 150(1):116-22. PubMed ID: 16084157
[TBL] [Abstract][Full Text] [Related]
2. Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) Phase II Angiographic Trial.
Giugliano RP; Roe MT; Harrington RA; Gibson CM; Zeymer U; Van de Werf F; Baran KW; Hobbach HP; Woodlief LH; Hannan KL; Greenberg S; Miller J; Kitt MM; Strony J; McCabe CH; Braunwald E; Califf RM;
J Am Coll Cardiol; 2003 Apr; 41(8):1251-60. PubMed ID: 12706917
[TBL] [Abstract][Full Text] [Related]
3. Improved speed and stability of ST-segment recovery with reduced-dose tenecteplase and eptifibatide compared with full-dose tenecteplase for acute ST-segment elevation myocardial infarction.
Roe MT; Green CL; Giugliano RP; Gibson CM; Baran K; Greenberg M; Palmeri ST; Crater S; Trollinger K; Hannan K; Harrington RA; Krucoff MW;
J Am Coll Cardiol; 2004 Feb; 43(4):549-56. PubMed ID: 14975462
[TBL] [Abstract][Full Text] [Related]
4. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial.
Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) investigators
Lancet; 2006 Feb; 367(9510):569-78. PubMed ID: 16488800
[TBL] [Abstract][Full Text] [Related]
5. Multicenter randomized trial of facilitated percutaneous coronary intervention with low-dose tenecteplase in patients with acute myocardial infarction: the Athens PCI trial.
Kanakakis J; Nanas JN; Tsagalou EP; Maroulidis GD; Drakos SG; Ntalianis AS; Tzoumele P; Skoumbourdis E; Charbis P; Rokas S; Anastasiou-Nana M
Catheter Cardiovasc Interv; 2009 Sep; 74(3):398-405. PubMed ID: 19360864
[TBL] [Abstract][Full Text] [Related]
6. Randomized comparison of eptifibatide versus abciximab in primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: results of the EVA-AMI Trial.
Zeymer U; Margenet A; Haude M; Bode C; Lablanche JM; Heuer H; Schröder R; Kropff S; Bourkaib R; Banik N; Zahn R; Teiger E
J Am Coll Cardiol; 2010 Aug; 56(6):463-9. PubMed ID: 20670755
[TBL] [Abstract][Full Text] [Related]
7. Randomized comparison of pre-hospital-initiated facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention in acute myocardial infarction very early after symptom onset: the LIPSIA-STEMI trial (Leipzig immediate prehospital facilitated angioplasty in ST-segment myocardial infarction).
Thiele H; Eitel I; Meinberg C; Desch S; Leuschner A; Pfeiffer D; Hartmann A; Lotze U; Strauss W; Schuler G;
JACC Cardiovasc Interv; 2011 Jun; 4(6):605-14. PubMed ID: 21700245
[TBL] [Abstract][Full Text] [Related]
8. Early initiation of eptifibatide in the emergency department before primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results of the Time to Integrilin Therapy in Acute Myocardial Infarction (TITAN)-TIMI 34 trial.
Gibson CM; Kirtane AJ; Murphy SA; Rohrbeck S; Menon V; Lins J; Kazziha S; Rokos I; Shammas NW; Palabrica TM; Fish P; McCabe CH; Braunwald E;
Am Heart J; 2006 Oct; 152(4):668-75. PubMed ID: 16996831
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial.
Gibson CM; Morrow DA; Murphy SA; Palabrica TM; Jennings LK; Stone PH; Lui HH; Bulle T; Lakkis N; Kovach R; Cohen DJ; Fish P; McCabe CH; Braunwald E;
J Am Coll Cardiol; 2006 Jun; 47(12):2364-73. PubMed ID: 16781360
[TBL] [Abstract][Full Text] [Related]
10. ST-segment recovery and prognosis in patients with ST-elevation myocardial infarction reperfused by prehospital combination fibrinolysis, prehospital initiated facilitated percutaneous coronary intervention, or primary percutaneous coronary intervention.
Thiele H; Scholz M; Engelmann L; Storch WH; Hartmann A; Dimmel G; Pfeiffer D; Schuler G;
Am J Cardiol; 2006 Nov; 98(9):1132-9. PubMed ID: 17056313
[TBL] [Abstract][Full Text] [Related]
11. Association between platelet receptor occupancy after eptifibatide (integrilin) therapy and patency, myocardial perfusion, and ST-segment resolution among patients with ST-segment-elevation myocardial infarction: an INTEGRITI (Integrilin and Tenecteplase in Acute Myocardial Infarction) substudy.
Gibson CM; Jennings LK; Murphy SA; Lorenz DP; Giugliano RP; Harrington RA; Cholera S; Krishnan R; Califf RM; Braunwald E;
Circulation; 2004 Aug; 110(6):679-84. PubMed ID: 15262838
[TBL] [Abstract][Full Text] [Related]
12. Primary percutaneous coronary angioplasty with and without eptifibatide in ST-segment elevation myocardial infarction: a safety and efficacy study of integrilin-facilitated versus primary percutaneous coronary intervention in ST-segment elevation myocardial infarction (ASSIST).
Le May MR; Wells GA; Glover CA; So DY; Froeschl M; Marquis JF; O'Brien ER; Turek M; Thomas A; Kass M; Jadhav S; Labinaz M
Circ Cardiovasc Interv; 2009 Aug; 2(4):330-8. PubMed ID: 20031736
[TBL] [Abstract][Full Text] [Related]
13. ST segment resolution in patients with tenecteplase-facilitated percutaneous coronary intervention versus tenecteplase alone: Insights from the Combined Angioplasty and Pharmacological Intervention versus Thrombolysis ALone in Acute Myocardial Infarction (CAPITAL AMI) trial.
So DY; Ha AC; Davies RF; Froeschl M; Wells GA; Le May MR
Can J Cardiol; 2010 Jan; 26(1):e7-12. PubMed ID: 20101370
[TBL] [Abstract][Full Text] [Related]
14. Early eptifibatide improves TIMI 3 patency before primary percutaneous coronary intervention for acute ST elevation myocardial infarction: results of the randomized integrilin in acute myocardial infarction (INTAMI) pilot trial.
Zeymer U; Zahn R; Schiele R; Jansen W; Girth E; Gitt A; Seidl K; Schröder R; Schneider S; Senges J
Eur Heart J; 2005 Oct; 26(19):1971-7. PubMed ID: 15857851
[TBL] [Abstract][Full Text] [Related]
15. A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) study.
Armstrong PW;
Eur Heart J; 2006 Jul; 27(13):1530-8. PubMed ID: 16757491
[TBL] [Abstract][Full Text] [Related]
16. Facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention: design and rationale of the Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events (FINESSE) trial.
Ellis SG; Armstrong P; Betriu A; Brodie B; Herrmann H; Montalescot G; Neumann FJ; Smith JJ; Topol E;
Am Heart J; 2004 Apr; 147(4):E16. PubMed ID: 15077099
[TBL] [Abstract][Full Text] [Related]
17. Facilitated percutaneous coronary intervention (PCI) in patients with acute ST-elevation myocardial infarction: comparison of prehospital tirofiban versus fibrinolysis before direct PCI.
Möckel M; Bocksch W; Strohm S; Kühnle Y; Vollert J; Nibbe L; Dietz R
Int J Cardiol; 2005 Aug; 103(2):193-200. PubMed ID: 16080980
[TBL] [Abstract][Full Text] [Related]
18. Administration of eptifibatide during transfer for primary PCI in patients with STEMI: effect on Pre-PCI TIMI flow and its correlation with pain-to-therapy time.
Aquilina M; Varani E; Balducelli M; Vecchi G; Frassineti V; Maresta A
J Invasive Cardiol; 2009 Mar; 21(3):115-20. PubMed ID: 19258642
[TBL] [Abstract][Full Text] [Related]
19. The role of eptifibatide in patients undergoing percutaneous coronary intervention.
Zeymer U
Expert Opin Pharmacother; 2007 Jun; 8(8):1147-54. PubMed ID: 17516878
[TBL] [Abstract][Full Text] [Related]
20. Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI Investigators.
Ohman EM; Kleiman NS; Gacioch G; Worley SJ; Navetta FI; Talley JD; Anderson HV; Ellis SG; Cohen MD; Spriggs D; Miller M; Kereiakes D; Yakubov S; Kitt MM; Sigmon KN; Califf RM; Krucoff MW; Topol EJ
Circulation; 1997 Feb; 95(4):846-54. PubMed ID: 9054741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]